Monday, 27 April 2009 08:00 - 08:50, Parkside 110A

Please join us for a delicious buffet breakfast as Dr Adrian (Adi) Paterson, the new CEO of ANSTO speaks about Australia’s nuclear future and the special place of clinical and research applications of nuclear technologies and radiopharmaceuticals. Dr Ron Weiner, Head of ANSTO’s Radiopharmaceutical Research Institute, will also discuss new compounds which are currently in clinical trials, as well as the production of 177Lu in the OPAL reactor. There will be an opportunity for engagement and discussion on the challenges facing the nuclear medicine community.

Bookings are essential as seats are limited – to reserve your place please email rri-admin@ansto.gov.au with your name, position title, company name, telephone and email details. "